SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-060984
Filing Date
2018-12-04
Accepted
2018-12-04 17:36:37
Documents
2
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1650
2 POA DOCUMENT poa.txt EX-24.3_819534 3443
  Complete submission text file 0001209191-18-060984.txt   6529
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ONCOBIOLOGICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address
Dagnon Terry (Reporting) CIK: 0001760510 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37759 | Film No.: 181217963